ONCTERNAL THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.03 USD | +0.33% |
|
+1.64% | -16.36% |
| 05-09 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 05-09 | Oncternal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.33% | +1.64% | -16.36% | +41.75% | - | 26.64M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ONCT Stock
- Charts Oncternal Therapeutics, Inc.
- Comparison Chart
